Surgical strategies and approaches for the management of tumors at cervicothoracic junction
10.3760/cma.j.cn112434-20200909-00414
- VernacularTitle:颈胸交界处肿瘤的手术入路和方法
- Author:
Shuai WANG
1
;
Lijie TAN
;
Di GE
;
Fazhi QI
;
Yong ZHANG
;
Ting ZHU
;
Zenggan CHEN
;
Wei JIANG
;
Qun WANG
Author Information
1. 复旦大学附属中山医院胸外科，上海 200032
- Keywords:
Tumors;
Cervicothoracic junction;
Surgical approach;
Hemiclamshell
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2021;37(6):358-362
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the surgical treatment of the tumors at cervicothoracic junction.Methods:A retrospective analyses was performed for 63 patients with tumors at the cervicothoracic junction receiving surgery from Mar 2008 to May 2020 in the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University. Clinical data about manifestation, surgical approach, resection degree and pathological types were collected. There were 43 cases of asymptomatic patients and 20 cases of patients with ≥1 clinical manifestations. Twenty two patients receiving radical resection with video-assisted thoracoscopic surgery. Anterior approach was the most popular treatment in open surgery (24 cases, 38.1%), and 8 cases of anterolateral approach(6 cases of Hemiclamshell incisions, 2 cases of trap-door incisions), 1 case of posterior approach, 2 cases of posterolateral approach and 1 case of supraclavicular combined posterolateral approach.Results:Pathological examination suggested 61 cases of radical resection and 2 cases of microscopic residual. Neurilemmoma was the most common pathological type (27 cases, 42.9%), the second common pathological type was tumor originated from fibrous tissues (6 cases, 9.5%). The 3-year overall survival rate of those 63 patients was 88.9%, while the 5-year overall survival rate was 84.1%.Conclusion:Tumors involving the cervicothoracic junction are characterized as special location, complicated anatomy and various histopathological subtypes. Individualized approach and surgery improve safety and normalization of tumors at cervicothoracic junction treatment.
